Evidence map›Paper›PMID 33807049›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Reduced Susceptibility to Chlorhexidine among

Maya Azrad, Chen Shmuel, Tamar Leshem, Zohar Hamo, Moti Baum, Assaf Rokney, Keren Agay-Shay, Avi Peretz

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Frontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Maya AzradClinical Microbiology Laboratory, The Baruch Padeh Medical Center, Poriya, Tiberias 1528001, Israel.ORCID 0000-0002-0966-2575
Chen ShmuelClinical Microbiology Laboratory, The Baruch Padeh Medical Center, Poriya, Tiberias 1528001, Israel.
Tamar LeshemClinical Microbiology Laboratory, The Baruch Padeh Medical Center, Poriya, Tiberias 1528001, Israel.
Zohar HamoClinical Microbiology Laboratory, The Baruch Padeh Medical Center, Poriya, Tiberias 1528001, Israel.
Moti BaumCentral Government Laboratories, Israel Ministry of Health, Jerusalem 9446724, Israel.ORCID 0000-0002-7422-2402
Assaf RokneyCentral Government Laboratories, Israel Ministry of Health, Jerusalem 9446724, Israel.
Keren Agay-ShayThe Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel.
Avi PeretzClinical Microbiology Laboratory, The Baruch Padeh Medical Center, Poriya, Tiberias 1528001, Israel.
Poriya Medical Center · ILBar-Ilan University · ILIsrael Ministry of Health · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antiseptic use for body decolonization is the main activity applied to prevent healthcare-associated infections, including those caused by

Indexed as

chlorhexidinegenotypic and phenotypic susceptibilityhealthcare-associated infectionsreduced susceptibilityS. aureus

Identifiers

PMID33807049
PMCPMC8005201
OpenAlexW3138617505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.